dc.contributor.author | Lee, K. H. | |
dc.contributor.author | Antonia, S. J. | |
dc.contributor.author | Villegas, A. | |
dc.contributor.author | Daniel, D. | |
dc.contributor.author | Vicente, D. | |
dc.contributor.author | Murakami, S. | |
dc.contributor.author | Hui, R. | |
dc.contributor.author | Yokoi, T. | |
dc.contributor.author | Chiappori, A. | |
dc.contributor.author | de Wit, M. | |
dc.contributor.author | Cho, B. C. | |
dc.contributor.author | Bourhaba, M. | |
dc.contributor.author | Quantin, X. | |
dc.contributor.author | Tokito, T. | |
dc.contributor.author | Mekhail, T. | |
dc.contributor.author | Planchard, D. | |
dc.contributor.author | Kim, Y. -C. | |
dc.contributor.author | Karapetis, C. S. | |
dc.contributor.author | Hiret, S. | |
dc.contributor.author | Ostoros, G. | |
dc.contributor.author | Kubota, K. | |
dc.contributor.author | Gray, J. E. | |
dc.contributor.author | Paz-Ares, L. | |
dc.contributor.author | de Castro Carpeno, J. | |
dc.contributor.author | Wadsworth, C. | |
dc.contributor.author | Melillo, G. | |
dc.contributor.author | Jiang, H. | |
dc.contributor.author | Huang, Y. | |
dc.contributor.author | Dennis, P. A. | |
dc.contributor.author | Ozguroglu, M. | |
dc.date.accessioned | 2021-03-06T21:31:35Z | |
dc.date.available | 2021-03-06T21:31:35Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Antonia S. J. , Villegas A., Daniel D., Vicente D., Murakami S., Hui R., Yokoi T., Chiappori A., Lee K. H. , de Wit M., et al., "Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer", NEW ENGLAND JOURNAL OF MEDICINE, cilt.377, ss.1919-1929, 2017 | |
dc.identifier.issn | 0028-4793 | |
dc.identifier.other | av_ff157ecb-1510-470c-90a7-9fa75299c760 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/166787 | |
dc.identifier.uri | https://doi.org/10.1056/nejmoa1709937 | |
dc.description.abstract | BACKGROUND | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer | |
dc.type | Makale | |
dc.relation.journal | NEW ENGLAND JOURNAL OF MEDICINE | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 377 | |
dc.identifier.issue | 20 | |
dc.identifier.startpage | 1919 | |
dc.identifier.endpage | 1929 | |
dc.contributor.firstauthorID | 247642 | |